The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fKZIJX
via IFTTT
0 comments:
Post a Comment